ArticleJournal of gastroenterology2018
Real-world efficacy and safety of ledipasvir and sofosbuvir in patients with hepatitis C virus genotype 1 infection: a nationwide multicenter study by the Japanese Red Cross Liver Study Group.
Keiji Tsuji et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
23 papers cite it
this papertrialcites it